Article info

Download PDFPDF
Prolonged treatment with Tadekinig alfa in adult-onset Still’s disease

Authors

  1. Correspondence to Professor Cem Gabay, Division of Rheumatology,Department of Internal Medicine Specialties, University Hospitals of Geneva, Geneva 1211, Switzerland; cem.gabay{at}hcuge.ch
View Full Text

Citation

Kiltz U, Kiefer D, Braun J, et al
Prolonged treatment with Tadekinig alfa in adult-onset Still’s disease

Publication history

  • Received September 27, 2018
  • Accepted September 29, 2018
  • First published October 23, 2018.
Online issue publication 
December 16, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.